Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34011988.
- Also identified by DOI 10.1038/s41467-021-23272-z and PMC identifier 8134551.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The association between reduced myofilament force-generating capacity (F<sub>max</sub>) and heart failure (HF) is clear, however the underlying molecular mechanisms are poorly understood. Here, we show impaired F<sub>max</sub> arises from reduced BAG3-mediated sarcomere turnover. Myofilament BAG3 expression decreases in human HF and positively correlates with F<sub>max</sub>. We confirm this relationship using BAG3 haploinsufficient mice, which display reduced F<sub>max</sub> and increased myofilament ubiquitination, suggesting impaired protein turnover. We show cardiac BAG3 operates via chaperone-assisted selective autophagy (CASA), conserved from skeletal muscle, and confirm sarcomeric CASA complex localization is BAG3/proteotoxic stress-dependent. Using mass spectrometry, we characterize the myofilament CASA interactome in the human heart and identify eight clients of BAG3-mediated turnover. To determine if increasing BAG3 expression in HF can restore sarcomere proteostasis/F<sub>max</sub>, HF mice were treated with rAAV9-BAG3. Gene therapy fully rescued F<sub>max</sub> and CASA protein turnover after four weeks. Our findings indicate BAG3-mediated sarcomere turnover is fundamental for myofilament functional maintenance.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Apoptosis Regulatory Proteins
- Heart Failure
- Myocytes, Cardiac